Position in GRAL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$25,345,441
+$9,731,053 QoQ
Shares Held
371,253
+22.9% QoQ
Ownership
0.831%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $1,347,844,187 across 35 Diagnostics & Research names. GRAL ranks #15 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
650,976 | $326,373,326 | |
| 2 | DHR |
Danaher Corp /De/
|
778,298 | $148,250,202 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
90,754 | $115,939,141 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
165,689 | $87,225,316 | |
| 5 | ILMN |
Illumina, Inc.
|
465,311 | $81,815,632 | |
| 6 | WAT |
Waters Corp /De/
|
213,227 | $79,968,652 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
316,217 | $71,714,852 | |
| 8 | DGX |
Quest Diagnostics Inc
|
315,584 | $66,888,027 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,345,441 | 371,253 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $15,614,388 | 302,136 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,780,234 | 67,534 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,938,227 | 49,691 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $3,324,507 | 64,654 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,619,407 | 102,561 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $764,907 | 42,852 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $118,430 | 8,607 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $474,500 | 30,872 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||